RSS-Feed abonnieren
DOI: 10.1055/s-2006-926248
Synthesis of Pyranonaphthoquinone Antibiotics Involving the Phthalide Annulation Strategy
Publikationsverlauf
Publikationsdatum:
20. Februar 2006 (online)
Abstract
The synthesis of the pyranonaphthoquinone antibiotic pentalongin was performed using the phthalide annulation strategy. Annulation of the cyanophthalide onto 6H-pyran-3-one resulted in a hongconin analogue, which upon further elaboration was converted into the natural product.
Key words
annulations - natural products - quinones - phthalide - pentalongin
- 1
Thomson RH. Naturally Occurring Quinones 2nd ed.: Academic Press; London: 1971. p.282 ; see also p. 597 - 2
Wang W.Li T.Milburn R.Yates J.Hinnant E.Luzzio MJ.Noble SA.Attardo G. Bioorg. Med. Chem. Lett. 1998, 8: 1579 -
3a
Hayashi T.Smith FT.Lee KH. J. Med. Chem. 1987, 30: 2005 -
3b
Lee H.Hong SH.Kim YH. Bioorg. Med. Chem. Lett. 1996, 8: 933 - 4
Brimble MA.Nairn MR.Prabaharan H. Tetrahedron 2000, 56: 1937 - 5
Naruta Y.Maruyama J. Recent Advances in the Synthesis of Quinonoid Compounds. The Chemistry of Quinonoid Compounds Vol. 2:Patai S.Rapoport Z. John Wiley; New York: 1988. p.241 -
7a
Hari L.De Buyck L.De Pooter HL. Phytochemistry 1991, 30: 1726 -
7b
De Kimpe N.Van Puyvelde L.Schripsema J.Erkelens C.Verpoorte R. Magn. Reson. Chem. 1993, 31: 329 - 8
Kesteleyn B.Van Puyvelde L.De Kimpe N. J. Org. Chem. 1999, 64: 438 - 9
Nguyen Van T.De Kimpe N. Tetrahedron Lett. 2004, 45: 3443 - 10
Kesteleyn B.De Kimpe N.Van Puyvelde L. J. Org. Chem. 1999, 64: 1173 - 11
Nguyen Van T.Kesteleyn B.De Kimpe N. Tetrahedron 2001, 57: 4213 - 12
Nguyen Van T.De Kimpe N. Tetrahedron 2003, 59: 5941 - 14
Pialat J.-P.Hoffmann P.Moulis C.Fouraste I.Labidalle S. Nat. Prod. Lett. 1998, 12: 23 - 15
Kesteleyn B.De Kimpe N.Van Puyvelde L. Synthesis 1999, 1881 - 16
Bulbule VJ.Koranne PS.Munot YS.Borate HB.Deshpande VH. Synth. Commun. 2003, 33: 587 - 17
Kobayashi K.Uchida M.Uneda T.Tanmatsu M.Morikawa O.Konishi H. Tetrahedron Lett. 1998, 39: 7725 - 18
Deshpande PP.Price KN.Baker DC. J. Org. Chem. 1996, 61: 455 - 19
Cossy J.Taillier C.Bellosta V. Tetrahedron Lett. 2002, 43: 7263 - 20
Eiden F.Wanner KT. Arch. Pharm. 1985, 548 -
21a
Kraus GA.Sugimoti H. Tetrahedron Lett. 1978, 2263 -
21b
Kraus GA.Cho H.Crowley S.Roth B.Sugimoto H.Prugh S. J. Org. Chem. 1983, 48: 3499 -
22a
Hauser FM.Mal D. J. Am. Chem. Soc. 1983, 105: 5688 -
22b
Hauser FM.Rhee RP. J. Org. Chem. 1978, 43: 178 -
22c
Hauser FM.Rhee RP. J. Am. Chem. Soc. 1979, 101: 1628 - 23
Mitchell AS.Russell RA. Tetrahedron 1995, 51: 5207 -
24a
Gould SJ.Melville CR. Tetrahedron Lett. 1997, 38: 1473 -
24b
Cone MC.Melville CR.Gore MP.Gould SJ. J. Org. Chem. 1993, 58: 1058 -
24c
Pedersen JA. Spectrochim. Acta, Part A 2002, 52: 1257 - 26
Giles RGF.Green IR.Taylor CP. Tetrahedron Lett. 1999, 40: 4871
References and Notes
Van Puyvelde, L.; Hakizayezu, D.; Brioen, P.; De Kimpe, N.; De Vroey, C.; Bogaerts, J.; Hakizamungu, E., presented at International Congress on Natural Products Research, July 31 to August 4, 1994; Halifax, Canada, 1994.
13De Kimpe, N.; Kesteleyn, B.; Nguyen, Van T.; Van Puyvelde, L. 18th International Congress of Heterocyclic Chemistry, July 29 to August 3, 2001; Yokohama, Japan, 2001, 120.
255,10-Dimethoxy-1 H -benzo[ g ]isochromene-4-one ( 13): yellowish oil; 1H NMR (acetone-d 6): δ = 3.90 (3 H, s, OCH3), 4.01 (3 H, s, OCH3), 4.30 (2 H, s, CH2C=O), 5.06 (2 H, s, CH2O), 7.62 (1 H, ddd, J = 8.4, 7.0, 1.4 Hz, CH-7), 7.73 (1 H, ddd, J = 8.4, 7.0, 1.4 Hz, CH-8), 8.11 (1 H, dd, J = 8.4, 1.4 Hz, CH-9), 8.34 (1 H, dd, J = 8.4, 1.4 Hz, CH-6). 13C NMR (acetone-d 6): δ = 62.13 (OCH3), 63.14 (OCH3), 64.46 (CH2O), 74.50 (CH2OC=O), 118.30 (Cquat), 122.01 (CH-9), 125.05 (CH-6), 126.84 (CH-7), 127.45 (Cquat), 129.08 (Cquat), 129.74 (CH-8), 131.74 (Cquat), 146.43 (Cquat), 155.64 (Cquat), 193.47 (C=O). IR (KBr): νmax 1689 (C=O) cm-1. MS (ES+): m/z = 258 [M+].
274-Hydroxy-3,4-dihydro-1 H -benzo[ g ]isochromene-5,10-dione ( 6): 1H NMR (CDCl3): δ = 3.86 (1 H, dd, J = 12.2, 3.8 Hz, CHCH a Hb), 4.03 (1 H, dd, J = 12.2, 3.5 Hz, CHCHa H b ), 4.49 (1 H, dd, J = 18.9, 1.65 Hz, OCH a Hb), 4.76 (1 H, dd, J = 18.9, 0.6 Hz, OCHa H b ), 4.82 (1 H, m, CHOH), 7.76 (2 H, m, CH7-CH8), 8.09 (2 H, m, CH6-CH9). 13C NMR (CDCl3): δ = 60.18 (CH2O), 63.23 (CHOH), 69.51 (CH2), 126.38 (C-6 or C-9), 126.63 (C-9 or C-6), 131.83 (2 × Cquat), 134.28 (C-7 and C-8), 140.58 (Cquat), 143.74 (Cquat), 183.84 (C=O), 184.59 (C=O). IR (KBr): νmax = 3468 (OH), 1661 (C=O) cm-1. MS (ES+): m/z (%) = 231 (15) [M + H+], 213 (100) [M+ - H2O].